The
National Family Welfare Programme provides the following contraceptive services
for spacing births:
a)
Condoms
b)
Oral Contraceptive Pill
c)
Intra Uterine Devices (IUD)
Whereas condoms and oral contraceptive pills are being provided
through free distribution scheme and social marketing scheme, IUD is being
provided only under free distribution scheme. Under Social Marketing Programme,
contraceptives, both condoms and oral pills are sold at subsidized rates. In
addition, contraceptives are commercially sold by manufacturing Companies under
their brand names also. Govt. of India does not provide any subsidy for the
commercial sale.
2. Condoms are made available to the
potential users by Government of India through the following schemes:
- Free Distribution Scheme
- Social Marketing Scheme
3. Free disbursement of condoms was
started with the objective of making them available to those who cannot afford
to pay for it. Under this Scheme, Department of Family Welfare procures condoms
with brand name NIRODH from various Indian Manufacturers and supply them to all
the States/UTs for distribution to the users free of cost through dispensaries,
hospitals, PHCs, Sub-Centres etc.
4. Social Marketing Programme of condom was
launched by the Govt. of India in 1968 with the objective of making condoms
available to those who can afford to pay nominally for it. Under this scheme,
three different varieties namely (i) New Lubricated Nirodh, (ii) ‘Deluxe
Nirodh’ and (iii) ‘Super Deluxe Nirodh”
are procured from the indigenous condom manufacturers and supplied to marketing
companies/NGOs (called Social Marketing Organizations) at subsidised rates for
sale in the open market . In addition, distributing companies i.e. SMOs are
permitted to market condoms under their own brand name. A promotional incentive of 10 paise per
condom sold for Deluxe and Super Deluxe varieties and 3 paise per condom sold
for New Lubricated variety is also being provided to the SMOs. Deluxe Nirodh is
also sold by State AIDS Control Societies through their NGOs net work.
5. The country is self sufficient in the production of condoms.
The names of manufacturers presently having rate contract with the department
alongwith their annual capacity are given below :
|
Firm |
Annual Capacity ( In Million Pieces) |
|
1. Hindustan Latex Ltd. |
600.00* |
|
2. TTK LIG |
321.28 |
|
3. Polar Latex Ltd. |
178.50 |
|
4. J.K. Ansell |
84.10 |
|
5.Suretex Prophylactics (India)
Ltd. |
60.00 |
|
6.Indus Medicare |
34.50 |
*As per MOU. For others on single shift basis.
6. The following Tables show the condoms
distributed under Free Supply and Social Marketing Programme and maximum retail
price charged under Social Marketing:
|
Distribution of Condoms under (i) Free
Supply and (ii) Social Marketing Programme |
||
|
(In
Million Pieces) |
||
|
Fiscal Year |
Free Supply |
Social Marketing |
|
1995-96 |
891.22 |
162.92 |
|
1996-97 |
741.70 |
263.25 |
|
1997-98 |
685.85 |
324.42 |
|
1998-99 |
674.70 |
348.74 |
|
1999-2000 |
624.36 |
477.74 |
|
2000-01 |
627.42 |
465.43 |
|
2001-02 |
733.00 |
438.79 |
|
2002-03 |
891.42 |
513.77 |
|
Retail Price (MRP) of Condoms under Social Marketing Programme |
||
|
Brand
Name |
No.
of Pieces Per Pack |
Retail
Price Per
Pack(Rs.) |
|
|
|
|
|
1. Ahsaas |
4 |
5.00 |
|
2. Bliss |
4 |
6.00 |
|
3. Deluxe Nirodh |
5 |
2.00 |
|
4. Masti |
4/10 |
5.00/10.00 |
|
5. Mauj |
5 |
5.00 |
|
6. Milan |
4 |
2.00 |
|
7. Mithun |
6/12 |
4.00/7.00 |
|
8. New Lubricated Nirodh |
3 |
0.50 |
|
9. Pick Me |
4 |
5.00 |
|
10. Sangam |
3 |
3.00 |
|
11. Sawan |
4 |
4.00 |
|
12. Super Deluxe Nirodh |
4 |
3.00 |
|
13. Ustad |
4 |
4.00 |
|
14. Zaroor |
3/12 |
4.00/12.00 |
|
15.Sathi |
4/10 |
5.00/10.00 |
|
16. Sparsh |
4/10 |
5.00/10.00 |
|
17. Thril |
4 |
5.00 |
7. Oral Contraceptive Pills are also made
available to the potential users by Government of India through the following
schemes:
- Free Distribution Scheme
- Social Marketing Scheme
8. Under the free distribution scheme Oral Contraceptive Pills with brand name Mala N
are procured and distributed to the acceptors free of cost in the same
manner as that of condoms.
9. On the pattern of Social Marketing
scheme of condoms, Social Marketing
Scheme of Oral Pills was launched by
the Govt. of India in 1987. Under this scheme, Government procure Mala
D from the indigenous manufacturers
and supply them to marketing
companies/NGOs (called Social Marketing Organizations) at subsidised rates.
Distributing companies i.e. SMOs are also permitted to market oral pills under their brand name. A promotional
incentive of Re. 0.25 per cycle of oral pills sold is also being provided to
the SMOs.
10. The raw material for Oral Contraceptives
Pills namely Levonorgestrel & Ethynloestradial have now been procured by
the Department from 2002-03 onwards. The tabletting of pills from the raw
material is done by the manufacturers .The manufacturers having rate contract
with the Department during the current year and their production capacities are
as under:
|
Firm |
Annual Capacity( In Million Cycles) |
|
1. M/s Pharmasia Ltd |
53.57 |
|
2. M/s Hindustan Latex Ltd |
51.86 |
|
3. M/s Famy Care Ltd |
49.65 |
|
4. M/s IDPL |
33.86 |
11. The following Tables show the Oral Pills
(one cycle consists of 28 tablets) distributed
under Free Supply and Social Marketing Programme and maximum retail price
charged under Social Marketing :
|
Distribution of Oral Pills under (i) Free
Supply and (ii) Social Marketing Programme |
||
|
(In
Lakh Cycles) |
||
|
Fiscal Year |
Free Supply |
Social Marketing |
|
1995-96 |
411.20 |
146.80 |
|
1996-97 |
397.94 |
162.42 |
|
1997-98 |
467.10 |
228.40 |
|
1998-99 |
452.32 |
255.08 |
|
1999-2000 |
488.98 |
349.03 |
|
2000-01 |
554.39 |
331.91 |
|
2001-02 |
528.54 |
403.32 |
|
2002-03 |
574.31 |
477.51 |
|
Retail Price (MRP) of Oral Pills under Social Marketing Programme |
||
Brand Name |
No. of Cycles Per Pack |
Retail Price Per Cycle(Rs.) |
|
|
|
|
|
1. Apsara |
1/3 |
4.00/10.00 |
|
2. Arpan |
1 |
5.00 |
|
3. Choice |
1 |
7.00 |
|
4. Ecroz |
1/3 |
6.00/10.00 |
|
5. Julie |
1 |
5.00 |
|
6. Mala D |
1 |
2.00 |
|
7. Pearl |
1/3 |
5.00/10.00 |
|
8. Suvida |
1/3 |
7.00/20.00 |
|
9.Khushi |
1 |
5.00 |
|
10.Hamjoli |
1/3 |
5.00/10.00 |
12. At present following SMOs are participating for distribution of contraceptives (Condoms/Oral Pills) under Social Marketing in India.
|
S/No |
Name of the SMO |
Condoms (Brand) |
Oral pills (Brand) |
|
|
Population Services
International , New Delhi |
Deluxe Nirodh, Masti |
Mala-D, Pearl |
|
|
Hindustan Latex Ltd., Thiruvananthapauram |
Deluxe Nirodh, New Lubricated
Nirodh,Ustad |
Mala-D, Arpan |
|
|
World Pharma, Indore |
Deluxe Nirodh, Mauj |
Mala-D, Julie |
|
|
Parivar Kalyan Kendra,
Panchkula |
Deluxe Nirodh, Pick me |
Mala-D Sugam |
|
|
Janani, Delhi |
Deluxe Nirodh, Mithun |
Mala-D,Apsara |
|
|
Parivar Seva Sanshtha, New Delhi |
Sawan, Bliss, Milan |
Ecroz |
|
|
DKT India, Mumbai |
Zaroor |
Choice |
|
|
Pashupati Chemicals &
Pharmaceuticals Ltd., Kolkata |
Ahsaas |
- |
|
|
Dey’s Medical Store (Mfg) Ltd,
Kolkata |
- |
Mala-D |
|
|
Eskag Pharma Pvt. Ltd., Kolkata
|
- |
Suvida |
|
|
Family Planning Association of
India, Mumbai |
Sangam |
- |
|
|
Indian Drugs &
Pharmaceutical Ltd., Gurgaon |
- |
Mala-D |
|
|
Population Health Services, Hyderabad |
Thril |
Khushi |
|
|
Medicon Enterprises ,Rohtak |
Sparsh |
|
|
|
Parivar, Patna |
Sathi |
Hamjoli |
13. Since December, 1995 Centchroman, a
non-steroidal weekly OCP for female
developed by Central Drugs Research institute (CDRI), Lucknow is socially
marketed by M/s Hindustan Latex Ltd. ( Public Sector) under the brand name
SAHELI for which product subsidy and
publicity support is being provided by
the Government. This pill is to be taken twice a week on
fixed days for first three months , followed by one pill in a week
thereafter.
14. The following Table shows the sale
of ‘Saheli’ since 1.12.1995 :
Fiscal Year Centchroman(Saheli)
(
In lakh tablets)
1995-96 44.17
(1.12.95 to 31.3.96)
1996-97 62.05
1997-98 94.06
1998-99 87.70
1999-2000
56.83
2000-01
63.98
2001-02 129.60
2002-03
135.58
15. Cu-T is one of the important spacing methods offered under the Family Welfare Programme. Cu-T is supplied free of cost to all the States/UTs for insertion at the PHCs, Sub-centres and Hospitals by trained Medical Practitioners/trained Health Workers.
16. The earlier version of Cu-T 200 ‘B’ (IUDs) has been replaced by Cu-T 380-A from 2002-03 onwards which provides protection for a longer period(about 10 years) as against Cu-T 200 ‘B’ which provided protection for about 3 years only.
The country has
a large production capacity of Copper
–T to meet country’s domestic need as well as export. The names of
manufacturers presently having rate contract with the Department and their
annual production capacity are given below:
|
Firm |
Annual Capacity (In Lakh Pieces) |
|
1. M/s Famy Care Ltd |
163.64 |
|
2. M/s SMB Corporation of India |
85.33 |
|
3. M/s Hindustan Latex Ltd |
59.20 |
|
4. M/s Contech Devices Pvt Ltd |
20.72 |
17. The use of Cu-T since 1995-96 is as
under:
|
Year |
Use of Cu T (In lakh Pieces) |
|
1995-96 |
68.58 |
|
1996-97 |
56.81 |
|
1997-98 |
61.73 |
|
1998-99 |
61.44 |
|
1999-2000 |
61.89 |
|
2000-01 |
60.03 |
|
2001-02 |
76.02 |
|
2002-03 |
75.18 |
18. Emergency Contraceptive Pill has been introduced for
the first time under Family Welfare Programme during 2002-03. The emergency contraceptive is the method
that can be used to prevent unwanted pregnancy after an unprotected act of
sexual intercourse ) including sexual assault, rape or sexual coercion) or a
contraceptive failures. Emergency
Contraceptive is to be taken on prescription of Medical Practitioners. A pack contain two tablets of
Levonorgentrel
19. In view of putting concerted efforts with
area specific projects, Social Marketing endeavours have been initiated in six
States- Madhya Pradesh, Haryana, Andhra Pradesh,. Bihar, Jharkhand and Orissa.
(i) To begin with, in 1998-99, the Department of Family Welfare had sanctioned a pilot project to M/s. Hindustan Latex Family Planning Promotion Trust, Thiruvananthapuram HLFPPT) of HLL, for strengthening Social Marketing of Contraceptives programme. The project has been implemented in three districts of Madhya Pradesh viz., Gwalior, Bhind and Morena. This has been extended up to 31.3.2001 with inclusion of two more adjacent districts namely; Shivpuri and Datia.
This project has been evaluated by
the International Institute for Population Sciences (IIPS), Mumbai in the
beginning of year 2000. The study
revealed that the model adopted by HLFPPT has made impact in rural areas also
and it may therefore be replicated in some demographically back ward districts
of other States.
(ii) Another area project on Social
Marketing sanctioned to the Society for Woman and Child Health in Haryana, has
been launched in the districts of Ambala, Kurukshetra, Panchkula and Yamuna
Nagar in April, 2000 for four years at a total cost of 1.32 crores.
(iii)
Encouraged by the success of these area projects as revealed from impact
evaluation conducted, a third project has been launched in Andhra Pradesh in
Feb., 2000 by M/s. Hindustan Latex Family Planning Promotion Trust,
Thiruvananthapuram (HLFPPT) of HLL, with the funding from European Commission,
at a total cost of Rs. 4.66 crores for a period of three years.
(iv)
Similar projects have been launched in the States of Bihar, Jharkhand and
Orissa being implemented by HLFPPT of
HLL.
(v) Collaboration with SIFPSA in Uttar
Pradesh: Hindustan Latex Limited(HLL)
is implementing a Rural Marketing Project (condoms and oral pills) awarded by
State Innovation in Family Planning Services Agency(SIFPSA) in all the
districts of Uttar Pradesh, since May,1997.
The Project has developed linkages with many NGOs and milk cooperative
societies in implementation. It fills a gap of such Social Marketing activities
in rural areas in the most populous State of the country and made appreciable
strides in this duration. After
completion of first project in April,2000, second project has been initiated in
May,2000 for covering 37,000 villages in entire Uttar Pradesh for a period of
three years, with SIFPSA funds.
20. Laparoscopes/Laparocators are essentially
required for undertaking Laparoscopic sterilization which is a relatively
quicker method of female sterilization. 25 Central Laparoscopic Training Centres
have been identified for the purpose of training medical and paramedical
personnel in this technique. The training is imparted to a team consisting of
Gynaecologist/Obst./Surgeons with minimum 3 years experience in the field,
Operation Theatre Nurse and Operation Theatre Attendant.
21. At present, Laparoscopes are supplied @
1.5 Laparoscope per trained team. To
meet this requirement, the Laparoscopes are procured centrally and distributed among
the States/UTs. Tubal Rings for this purpose are also procured centrally and
distributed to the States/UTs as per their demand.
22. Under
the Immunization Programme, Department
supplies six vaccines for vaccinations to infants and pregnant women for
the control of vaccine preventable diseases.
The names of manufacturers having rate contract with the Department
during the current year and their production capacity are as under:
|
Vaccine |
Name of manufacturing unit |
Annual Capacity ( In m. pcs.) |
|
Tatanus
Toxoid Vaccine |
1.
M/s. Biological Evens Ltd. Hyderabad |
120 |
|
|
2.
Serum Institute, Pune |
96 |
|
|
3.
M.s. Haffkine Bio-Pharmaceuticals Mumbai |
71.2 |
|
|
4.
Central Research Institute, Kasauli |
30 |
|
|
5.
M/s. Pasteur Institute of India,
Coonoor |
30 |
|
|
6.
State Vaccine Institute, Patwadangar Nainital |
10 |
|
DT
Vaccine |
1.
M/s. Biological Evens Ltd. Hyderabad |
24 |
|
|
2.
Central Research Institute, Kasuali |
20 |
|
|
3.
M/s. Pasteur Institute of India, Coonoor |
15 |
|
|
4.
M/s. Haffkine Bio-Pharmacuticals Mumbai |
10 |
|
DPT
Vaccine |
1.
Serum Institute of India, Pune |
97.5 |
|
|
2.
M/s. Biological Evans Ltd. Hyderabad |
80.0 |
|
|
3.
M/s. Haffkine Bio-Pharmaceuticals Mumbai |
44.8 |
|
|
4. M/s. Pasteur Institute of India, Coonoor |
40.00 |
|
|
5.
Central Research Institute Kasauli |
25 |
|
Measles
Vaccine |
1.
Serum Institute of India, Pune |
100 |
|
BCG
Vaccine |
1. BCG Vaccine Laboratory, Guindy, Tamil Nadu |
35 |
|
OralPolioVaccine
|
1.
M/s. Radicura Pharma New Delhi |
540 |
|
|
2.
M/s. BIBCOL, Bulandshahar |
300 |
|
|
3.
M/s. Haffkine Bio Pharmaceutical, Mumbai |
240 |
|
|
4.
M/s. Biomed, Ghaziabad |
156 |